Eisai Subsidiary Obtains Approvals For Two Medical Devices
This article was originally published in PharmAsia News
Tokyo-based Eidia, a diagnostic device maker and subsidiary of Eisai Co. Ltd. has obtained regulatory approvals in Japan for diagnostic Pronto CO2L and its catheter set
You may also be interested in...
Pink Sheet Podcast: Merck’s Frazier Speaks Out, US FDA’s Hahn On Decisions, Operation Warp Speed, Worries About User Fee Goal Delays
Pink Sheet reporters and editor discuss Merck CEO Ken Frazier’s thoughts on racial inequity, FDA Commissioner’s explanation of coronavirus decision-making and Operation Warp Speed changes, and consider fears about the potential for user fee goal delays.
On this week’s podcast the commercial team discuss strategies medtech companies can take to recover from the impact of COVID-19, and a new $100m Pandemic Innovation Fund launched by Israeli investment firm OurCrowd.
Early interaction with the European Medicines Agency is recommended if companies are planning to incorporate digital technologies into their drug development plans.